MDxHealth SA ADR (MDXH)

Currency in USD
0.1082
-0.0092(-7.84%)
Real-time Data·

MDXH Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.16 / -0.09
Revenue / Forecast
22.71M / 28.75M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2026--/-0.076--/30.77M----Free Sign Up
09/2026-0.160/-0.09022.71M/28.75M-77.78%-21.01%Free Sign Up
06/2026-0.180/-0.17027.21M/25.89M-5.88%+5.1%Free Sign Up
03/2026-0.170/-0.15027.40M/31.12M-13.33%-11.95%Free Sign Up
12/2025-0.170/-0.13029.50M/30.29M-30.77%-2.61%Free Sign Up
09/2025-0.160/-0.11027.40M/28.12M-45.45%-2.56%Free Sign Up
06/2025-0.140/-0.11726.61M/26.34M-19.97%+1.03%Free Sign Up
03/2025-0.190/-0.18024.30M/24.14M-5.56%+0.66%Free Sign Up
12/2024-0.140/-0.19024.74M/22.90M+26.32%+8.03%Free Sign Up
09/2024-0.400/-0.27023.30M/21.44M-48.15%+8.68%Free Sign Up

All numbers in USD

MDxHealth SA ADR Earnings Call Summary for Q3/2026

  • MDxHealth Q3 revenue of $22.7M missed consensus by 21%, falling to $28.75M forecast amid sales-force turnover and commercial disruption.
  • Gross margin compressed 320bps to 61.8% as product mix shifted toward lower-margin liquid testing; operating loss widened to $8.1M from $4.4M.
  • Management called Q3 the 'low point,' expects Q4 flat sequentially with recovery beginning 2027 as new sales reps ramp over 1-2 quarters.
  • Company restructuring sales organization after accelerated turnover from Resolve UTI wind-down; aims for full staffing by end of Q4 2026.
  • Shares fell 4.44% to $0.14 but rebounded 6.79% after-hours; cash at $31.7M raises concerns about burn rate amid widening losses.
Last Updated: 11/13/2026, 06:14 AM
Read Full Transcript

FAQ

What Is MDxHealth ADR's Earnings Per Share (TTM)?

The MDxHealth ADR EPS (TTM) is -0.68.

When Is The Next MDxHealth ADR Earnings Date?

MDxHealth ADR will release its next earnings report on Mar 03, 2027.

What Is MDxHealth ADR’s Revenue Forecasts For Upcoming Quarters?

MDxHealth ADR’s revenue forecast is 30.77M.

How Did MDxHealth ADR React to the Company's Latest Earnings Report?

MDxHealth ADR reported a -77.78% EPS surprise and a -21.01% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -1.6400%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.